Management of Achalasia

Gastroenterology Clinics of North America

Volumn 42, Issue 1, 2013, Pages 45-55

  Moonen, An J ^a   Boeckxstaens, Guy E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Achalasia; Botilinum toxin; Laparoscopic Heller myotomy; Peroral endoscopic myotomy; Pneumatic dilation

Indexed keywords

BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT;

BALLOON DILATATION; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPHAGIA; EARLY DIAGNOSIS; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS MANOMETRY; ESOPHAGUS MYOTOMY; ESOPHAGUS PERFORATION; FLUOROSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERIPHERAL EDEMA; PNEUMATIC DILATION; PROGNOSIS; RETREATMENT; REVIEW; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT RESPONSE; WEIGHT REDUCTION;

BOTULINUM TOXINS, TYPE A; DILATATION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGOSCOPY; HUMANS; LAPAROSCOPY; MANOMETRY;

EID: 84875328726     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2012.11.009     Document Type: Review

References (62)

1. Boeckxstaens G.E. The lower oesophageal sphincter. Neurogastroenterol Motil 2005, 17(Suppl 1):13-21.
2. Fisichella P.M., Raz D., Palazzo F., et al. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg 2008, 32(9):1974-1979.
3. Gockel I., Eckardt V.F., Schmitt T., et al. Pseudoachalasia: a case series and analysis of the literature. Scand J Gastroenterol 2005, 40(4):378-385.
4. Howard P.J., Maher L., Pryde A., et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992, 33(8):1011-1015.
5. Boeckxstaens G., Zaninotto G. Achalasia and esophago-gastric junction outflow obstruction: focus on the subtypes. Neurogastroenterol Motil 2012, 24(Suppl 1):27-31.
6. Pandolfino J.E., Kwiatek M.A., Nealis T., et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008, 135(5):1526-1533.
7. Lake J.M., Wong R.K. Review article: the management of achalasia - a comparison of different treatment modalities. Aliment Pharmacol Ther 2006, 24(6):909-918.
8. Hoogerwerf W.A., Pasricha P.J. Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am 2001, 11(2):311-324. vii.
9. Annese V., Bassotti G., Coccia G., et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut 2000, 46(5):597-600.
10. Friedenberg F., Gollamudi S., Parkman H.P. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004, 49(2):165-175.
11. Vittal H., Pasricha P.F. Botulinum toxin for gastrointestinal disorders: therapy and mechanisms. Neurotox Res 2006, 9(2-3):149-159.
12. Fishman V.M., Parkman H.P., Schiano T.D., et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996, 91(9):1724-1730.
13. Mikaeli J., Fazel A., Montazeri G., et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther 2001, 15(9):1389-1396.
14. Vaezi M.F., Richter J.E., Wilcox C.M., et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999, 44(2):231-239.
15. Eckardt V.F., Gockel I., Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004, 53(5):629-633.
16. Vela M.F., Richter J.E., Khandwala F., et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 2006, 4(5):580-587.
17. West R.L., Hirsch D.P., Bartelsman J.F., et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 2002, 97(6):1346-1351.
18. Zerbib F., Thetiot V., Richy F., et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006, 101(4):692-697.
19. Farhoomand K., Connor J.T., Richter J.E., et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004, 2(5):389-394.
20. Eckardt V.F., Kanzler G., Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc 1997, 45(5):349-353.
21. Ghoshal U.C., Kumar S., Saraswat V.A., et al. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence. Am J Gastroenterol 2004, 99(12):2304-2310.
22. Hulselmans M., Vanuytsel T., Degreef T., et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010, 8(1):30-35.
23. Vaezi M.F., Baker M.E., Achkar E., et al. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 2002, 50(6):765-770.
24. Guardino J.M., Vela M.F., Connor J.T., et al. Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol 2004, 38(10):855-860.
25. Richter J.E. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008, 2(3):435-445.
26. Vanuytsel T., Lerut T., Coosemans W., et al. Conservative management of esophageal perforations during pneumatic dilation for idiopathic esophageal achalasia. Clin Gastroenterol Hepatol 2012, 10(2):142-149.
27. Boeckxstaens G.E., Annese V., des Varannes S.B., et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med 2011, 364(19):1807-1816.
28. Oelschlager B.K., Chang L., Pellegrini C.A. Improved outcome after extended gastric myotomy for achalasia. Arch Surg 2003, 138(5):490-495.
29. Rebecchi F., Giaccone C., Farinella E., et al. Randomized controlled trial of laparoscopic Heller myotomy plus Dor fundoplication versus Nissen fundoplication for achalasia: long-term results. Ann Surg 2008, 248(6):1023-1030.
30. Campos G.M., Vittinghoff E., Rabl C., et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009, 249(1):45-57.
31. Chen Z., Bessell J.R., Chew A., et al. Laparoscopic cardiomyotomy for achalasia: clinical outcomes beyond 5 years. J Gastrointest Surg 2010, 14(4):594-600.
32. Snyder C.W., Burton R.C., Brown L.E., et al. Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic Heller myotomy for achalasia. J Gastrointest Surg 2009, 13(12):2095-2103.
33. Pallati P.K., Mittal S.K. Operative interventions for failed heller myotomy: a single institution experience. Am Surg 2011, 77(3):330-336.
34. Lopushinsky S.R., Urbach D.R. Pneumatic dilatation and surgical myotomy for achalasia. JAMA 2006, 296(18):2227-2233.
35. Richter J.E. A young man with a new diagnosis of achalasia. Clin Gastroenterol Hepatol 2008, 6(8):859-863.
36. Inoue H., Minami H., Kobayashi Y., et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010, 42(4):265-271.
37. von R.D., Inoue H., Minami H., et al. Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study. Am J Gastroenterol 2012, 107(3):411-417.
38. Hungness E.S., Teitelbaum E.N., Santos B.F., et al. Comparison of Perioperative Outcomes Between Peroral Esophageal Myotomy (POEM) and Laparoscopic Heller Myotomy. J Gastrointest Surg 2012, [Epub ahead of print].
39. Spechler S.J. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999, 117(1):233-254.
40. Vaezi M.F., Richter J.E. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 1999, 94(12):3406-3412.
41. Richter J.E., Boeckxstaens G.E. Management of achalasia: surgery or pneumatic dilation. Gut 2011, 60(6):869-876.
42. Zaninotto G., Costantini M., Rizzetto C., et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008, 248(6):986-993.
43. Gerson L.B. Pneumatic dilation or myotomy for achalasia?. Gastroenterology 2007, 132(2):811-813.
44. Eckardt A.J., Eckardt V.F. Editorial: Cancer surveillance in achalasia: better late than never?. Am J Gastroenterol 2010, 105(10):2150-2152.
45. Leeuwenburgh I., Scholten P., Alderliesten J., et al. Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 2010, 105(10):2144-2149.
46. Hirota W.K., Zuckerman M.J., Adler D.G., et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006, 63(4):570-580.
47. Eckardt V.F., Aignherr C., Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992, 103(6):1732-1738.
48. Vela M.F., Richter J.E., Wachsberger D., et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol 2004, 99(6):1029-1036.
49. Rohof W.O., Hirsch D.P., Kessing B.F., et al. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology 2012, 143(2):328-335.
50. Ellis F.H., Watkins E., Gibb S.P., et al. Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg 1992, 6(2):86-89.
51. Okike N., Payne W.S., Neufeld D.M., et al. Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg 1979, 28(2):119-125.
52. Duranceau A., Liberman M., Martin J., et al. End-stage achalasia. Dis Esophagus 2012, 25(4):319-330.
53. Zaninotto G., Rizzetto C., Zambon P., et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg 2008, 95(12):1488-1494.
54. Just-Viera J.O., Morris J.D., Haight C. Achalasia and esophageal carcinoma. Ann Thorac Surg 1967, 3(6):526-538.
55. Porschen R., Molsberger G., Kuhn A., et al. Achalasia-associated squamous cell carcinoma of the esophagus: flow-cytometric and histological evaluation. Gastroenterology 1995, 108(2):545-549.
56. Streitz J.M., Ellis F.H., Gibb S.P., et al. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995, 59(6):1604-1609.
57. Ellis F.H., Gibb S.P., Balogh K., et al. Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature. Dis Esophagus 1997, 10(1):55-60.
58. Feczko P.J., Ma C.K., Halpert R.D., et al. Barrett's metaplasia and dysplasia in postmyotomy achalasia patients. Am J Gastroenterol 1983, 78(5):265-268.
59. Kawahara Y., Uedo N., Fujishiro M., et al. The usefulness of NBI magnification on diagnosis of superficial esophageal squamous cell carcinoma. Dig Endosc 2011, 23(Suppl 1):79-82.
60. Uedo N., Fujishiro M., Goda K., et al. Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: current consensus of experienced endoscopists in Asia-Pacific region. Dig Endosc 2011, 23(Suppl 1):58-71.
61. Dawsey S.M., Fleischer D.E., Wang G.Q., et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998, 83(2):220-231.
62. Freitag C.P., Barros S.G., Kruel C.D., et al. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Dis Esophagus 1999, 12(3):191-195.